Secondary Prevention Therapies for AMI Part I: Aspirin an ADP Antagonists - Deepak Bhatt, MD

Target Audience

• Interventional Cardiologists
• Interventional Fellows

Sponsored by the Cardiovascular Research Foundation through an educational grant from Merck & Company

Session Name: Satellite Symposium: Novel Therapeutic Pathways in the Secondary Prevention of Atherothrombotic Events in AMI

Learning Objectives

• Update in advances in the Prevention of Atherothrombotic Events in AMI

Other Components in this Moment